An extremely good and important point to remember, people that are trialling new drugs are certainly not the average person walking down the street, they are normally very unwell people who have not had much success improving health wise with any other drug(s) meant to assist their particular medical issues. Mark will obviously be very preoccupied today with this news, I'm certain a through explanation will be forthcoming when all pertinent information is analysed.
- Forums
- ASX - By Stock
- kynamro: the malignancies are a “new concern”
An extremely good and important point to remember, people that...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.2¢ |
Change
-0.003(3.53%) |
Mkt cap ! $85.01M |
Open | High | Low | Value | Volume |
8.5¢ | 8.6¢ | 8.2¢ | $103.7K | 1.237M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 204084 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 280000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 204084 | 0.082 |
3 | 287000 | 0.081 |
8 | 672686 | 0.080 |
6 | 413817 | 0.079 |
6 | 689399 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 280000 | 3 |
0.086 | 96543 | 1 |
0.088 | 27962 | 1 |
0.089 | 200000 | 1 |
0.090 | 604764 | 4 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online